Alembic Gets USFDA Nod for Sumatriptan Injection Autoinjector Kumar Jeetendra | November 10, 2025 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Sumatriptan Injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, Single-Dose Autoinjector System. The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Imitrex STATdose System, …
Common mistakes in pharma equipment disinfection and how to avoid them Kumar Jeetendra | November 9, 2025 A few months back, a leading Indian pharmaceutical company lost an entire production batch, bearing almost a ₹20 crore loss. The culprit was a tiny trace of residue on a mixing blade. No formulation error. No equipment failure. Just inadequate disinfection. These stories don’t make headlines, but they’re far more common than the industry likes …
Alembic Pharma Gets USFDA Nod for Ticagrelor 60 mg Tablets Kumar Jeetendra | November 1, 2025 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg. The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Brilinta Tablets, 60 mg, of AstraZeneca Pharmaceuticals LP (AstraZeneca). Ticagrelor tablets are …
Alembic & Amlan Launch MinerTox-Z and MinerTox-A Kumar Jeetendra | October 9, 2025 Alembic Pharmaceuticals Ltd., through a strategic agreement with Amlan International, today announced the India launch of MinerTox-Z and MinerTox-A, feed additive solutions developed to protect poultry against toxins and enhance farm productivity. The introduction of these products represents an important step in addressing one of the poultry industry’s most pressing challenges—losses caused by toxins. By …
Pharma 2030: AI, Automation & The Next Era of Drug Development Kumar Jeetendra | October 6, 2025 For the first time in its chronicle, the pharmaceutical industry is on the verge of crossing a transformative threshold. The next decade and a half will not focus on the completion of incremental improvements but on the determining of a new paradigm in the intricate relationship of science and technology. The paradigm will focus on …
Alembic Pharma Gets EIR for API-I & II Facility at Panelav Kumar Jeetendra | September 15, 2025 Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) for the inspection conducted by the US Food and Drug Administration (USFDA) at its API-I and API-II facilities in Panelav. The inspection was carried out between May 26, 2025 and May 31, 2025. About Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited, a vertically integrated research and …
Cipla Launches HUENA®, India’s First Non-Antibiotic UTI Drug Kumar Jeetendra | September 8, 2025 Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced the launch of Methenamine Hippurate, a non-antibiotic treatment for patients suffering from recurrent urinary tract infections (UTIs), under the brand name HUENA. This marks a significant step forward for Cipla in the fight against Anti-Microbial Resistance (AMR) and reinforces its commitment …
Enteromix: Russia’s mRNA Vaccine for Colon Cancer Kumar Jeetendra | September 7, 2025 The Eastern Economic Forum, which took place from September 3 to September 6, 2025, in Vladivostok and is known for its landmark announcements, heard for the first time about Russia’s mRNA-based cancer vaccine, Enteromix, from the Federal Medical and Biological Agency (FMBA) of Russia. As per the available information, the vaccine has passed the preclinical …
Unplugging the Brain:The Science and Myths of Dopamine Detox Kumar Jeetendra | September 1, 2025 These days with all of the distractions notification sounds bring, as well as streaming sites and social media, the world as a whole can feel overwhelming. This overwhelming feeling explains why the phrase “dopamine detox” has gained a foothold in both productivity and wellness circles. The idea has practical outcomes where the elimination of stimulating …
Cipla Invests in iCaltech to Boost Respiratory Portfolio Kumar Jeetendra | July 22, 2025 Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced today that it has signed definitive agreements for investment in Optionally Convertible Preference Shares of iCaltech Innovations Private Limited (hereafter referred to as “iCaltech”), subject to completion of certain conditions. Cipla Invests in iCaltech to Strengthen Respiratory Diagnostics Ecosystem in India …
Common side effects of lisdexamfetamine explained Kumar Jeetendra | July 4, 2025 Unlike other medications, Vyvanse (Lisdexamfetamine) is one of the most prescribed medications for Attention Deficit Disorder (ADD), Hyperactivity Disorder (ADHD) and binge eating disorder (BED). Due to the fact that it has a once-a-day dosing and gentler onset it is preferred by a lot of doctors and patients. But as with all medications it does carry …
How Kimchi Pharma Probiotics Can Help Your Gut Health Kumar Jeetendra | July 4, 2025 The intersection where ancient techniques of fermentation meet modern pharmaceutical technology. That is the goal of kimchi Pharma Probiotics, which aims to strengthen dietary supplements for gut health with rigorous scientific refinement inspired by Korea’s representative fermented dish. The increased consumption of processed foods, coupled with the stressed lifestyles of people, has emerged as a …
